S. Chambers

977 total citations
22 papers, 761 citations indexed

About

S. Chambers is a scholar working on Pathology and Forensic Medicine, General Health Professions and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Chambers has authored 22 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in General Health Professions and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Chambers's work include Ovarian cancer diagnosis and treatment (5 papers), Breast Cancer Treatment Studies (5 papers) and Breast Lesions and Carcinomas (3 papers). S. Chambers is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Breast Cancer Treatment Studies (5 papers) and Breast Lesions and Carcinomas (3 papers). S. Chambers collaborates with scholars based in Canada, United Kingdom and United States. S. Chambers's co-authors include Stephen Birch, Mark N. Levine, Timothy J. Whelan, Andrew R. Willan, Amiram Gafni, Mary Ann O’Brien, Susan Reid, Sacha Dubois, John Eyles and Brian Hutchison and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

S. Chambers

22 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Chambers Canada 11 369 147 144 133 108 22 761
Reed E. Drews United States 17 101 0.3× 305 2.1× 71 0.5× 232 1.7× 46 0.4× 43 1.0k
Ariela L. Marshall United States 20 157 0.4× 161 1.1× 38 0.3× 297 2.2× 63 0.6× 90 1.3k
Amy Law United States 18 133 0.4× 124 0.8× 49 0.3× 365 2.7× 67 0.6× 75 1.1k
Justyna Bartoszko Canada 11 46 0.1× 83 0.6× 106 0.7× 31 0.2× 55 0.5× 39 856
Christel Le Petit Canada 8 51 0.1× 202 1.4× 134 0.9× 53 0.4× 76 0.7× 12 489
Ron Pritzkuleit Germany 17 156 0.4× 507 3.4× 165 1.1× 108 0.8× 57 0.5× 61 901
Manuela Quaresma United Kingdom 14 105 0.3× 656 4.5× 172 1.2× 128 1.0× 79 0.7× 29 1.1k
Barbara Matthews United States 13 53 0.1× 494 3.4× 132 0.9× 106 0.8× 44 0.4× 20 987
Neerav Monga Canada 14 58 0.2× 193 1.3× 18 0.1× 99 0.7× 97 0.9× 28 718
Maria Theresa Redaniel United Kingdom 19 81 0.2× 387 2.6× 74 0.5× 194 1.5× 57 0.5× 66 941

Countries citing papers authored by S. Chambers

Since Specialization
Citations

This map shows the geographic impact of S. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chambers more than expected).

Fields of papers citing papers by S. Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chambers. The network helps show where S. Chambers may publish in the future.

Co-authorship network of co-authors of S. Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chambers. A scholar is included among the top collaborators of S. Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chambers. S. Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riaz, Nazia, Bingshu E. Chen, Anita Bane, et al.. (2023). Abstract P4-02-16: Prognostic and Predictive Capacity of Tumor Infiltrating Lymphocytes in the MA.20 regional radiotherapy trial. Cancer Research. 83(5_Supplement). P4–2. 3 indexed citations
2.
Théberge, Valérie, Sawyna Provencher, Michael Yassa, et al.. (2021). OPAR: A Multicenter Phase II Randomized Trial of Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (APBI). International Journal of Radiation Oncology*Biology*Physics. 111(3). S6–S6. 6 indexed citations
3.
Mukherjee, Som D., et al.. (2019). Surgical Attitudes toward Preoperative Breast Magnetic Resonance Imaging in Women with Early-Stage Breast Cancer. Current Oncology. 26(2). 194–201. 4 indexed citations
4.
Mukherjee, Som D., Nicole Hodgson, Peter Lovrics, et al.. (2016). A Retrospective Study Evaluating the Impact of Preoperative Breast MRI on Surgical Decision-Making in Young Patients (≤50 Years) with Invasive Breast Cancer. Breast Cancer Basic and Clinical Research. 10. BCBCR.S38432–BCBCR.S38432. 12 indexed citations
5.
Vandermeer, R, S. Chambers, Alje P. van Dam, et al.. (2015). Diagnosing Lung Cancer in the 21st Century: Are We Ready to Meet the Challenge of Individualized Care?. Current Oncology. 22(4). 272–278. 8 indexed citations
6.
Bane, Anita, Timothy J. Whelan, Gregory R. Pond, et al.. (2014). Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. Annals of Oncology. 25(5). 992–998. 67 indexed citations
7.
Whelan, Timothy J., Mark N. Levine, Andrew R. Willan, et al.. (2004). Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery. JAMA. 292(4). 435–435. 331 indexed citations
8.
O’Malley, David M., Jacob Tangir, Masoud Azodi, et al.. (2004). Carboplatin/Paclitaxel as adjuvant therapy for stage III endometrial adenocarcinoma. Journal of Clinical Oncology. 22(14_suppl). 5071–5071. 1 indexed citations
9.
Heddle, Nancy M., Luba Klama, Ralph M. Meyer, et al.. (1999). A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion. 39(3). 231–238. 113 indexed citations
10.
Lim, Aaron G., Chris Walker, S. Chambers, & S R Gould. (1997). Helicobacter pylori eradication using a 7‐day regimen of low‐dose clarithromycin, lansoprazole and amoxycillin. Alimentary Pharmacology & Therapeutics. 11(3). 537–540. 10 indexed citations
11.
Broadbent, Andrew, et al.. (1996). A seven‐day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate.. Alimentary Pharmacology & Therapeutics. 10(3). 279–283. 13 indexed citations
12.
Heddle, Nancy M., Luba Klama, John G. Kelton, et al.. (1995). The use of anti‐D to improve post‐transfusion platelet response: a randomized trial. British Journal of Haematology. 89(1). 163–168. 12 indexed citations
13.
Harris, Anthony, et al.. (1995). Seroprevalence of Helicobacter pylori in residents of a hospital for people with severe learning difficulties.. PubMed. 7(1). 21–3. 21 indexed citations
14.
Eyles, John, Stephen Birch, & S. Chambers. (1994). FAIR SHARES FOR THE ZONE: ALLOCATING HEALTH‐CARE RESOURCES FOR THE NATIVE POPULATIONS OF THE SIOUX LOOKOUT ZONE, NORTHERN ONTARIO. Canadian Geographies / Géographies canadiennes. 38(2). 134–150. 9 indexed citations
15.
Price, Fredric V., S. Chambers, J.T. Chambers, et al.. (1993). Colony‐stimulating factor‐1 in primary ascites of ovarian cancer is a significant predictor of survival. International Journal of Gynecology & Obstetrics. 43(1). 98–98. 1 indexed citations
16.
Birch, Stephen, John Eyles, Jeremiah Hurley, Brian Hutchison, & S. Chambers. (1993). A Needs-Based Approach to Resource Allocation in Health Care. Canadian Public Policy. 19(1). 68–68. 29 indexed citations
17.
Hayden, Cheryl L., et al.. (1992). Prognostic variables for ovarian cancer. Gynecologic Oncology. 45(1). 105–105. 2 indexed citations
18.
Kacinski, Barry M., et al.. (1991). Expression of the neu oncogene in benign, borderline, and invasive ovarian neoplasms and carcinoma-derived cell lines. Gynecologic Oncology. 40(2). 183–183. 2 indexed citations
19.
Eyles, John, Stephen Birch, S. Chambers, Jeremiah Hurley, & Brian Hutchison. (1991). A needs-based methodology for allocating health care resources in Ontario, Canada: Development and an application. Social Science & Medicine. 33(4). 489–500. 74 indexed citations
20.
Schwartz, Peter E., J.T. Chambers, E.I. Kohorn, et al.. (1989). Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer: A prospective randomized trial. Gynecologic Oncology. 32(1). 100–100. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026